Pamela G. Marrone - 14 May 2021 Form 4 Insider Report for MARRONE BIO INNOVATIONS INC

Role: Director
Signature: /s/ Linda V. Moore, as attorney-in-fact
Issuer symbol: N/A
Transactions as of: 14 May 2021
Net transactions value: +$19,468
Form type: 4
Filing time: 17 May 2021, 16:39:22 UTC
Next filing: 11 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MBII	Common Stock	Options Exercise	$19,468	+13,807	+0.61%	$1.41	2,278,077	14 May 2021	Direct
holding	MBII	Common Stock						53,134	14 May 2021	Jointly with Spouse	F1
holding	MBII	Common Stock						6,442	14 May 2021	See Footnote

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MBII	Stock Option (Right to buy)	Options Exercise	$0	-13,807	-100%	$0.000000^*	0	05 Sep 2014	Common Stock	13,807	$1.41	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Ownership is held by Florence H. Marrone TOD Pamela G. Marrone.
F2	The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of August 11, 2016, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months.